Norton Waterford Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NORTON WATERFORD, and when can generic versions of NORTON WATERFORD drugs launch?
NORTON WATERFORD has one approved drug.
There are eight US patents protecting NORTON WATERFORD drugs.
There are two hundred and fifteen patent family members on NORTON WATERFORD drugs in twenty-seven countries.
Summary for Norton Waterford
International Patents: | 215 |
US Patents: | 8 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Norton Waterford
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-001 | Aug 3, 2017 | RX | Yes | No | 10,022,510 | See Plans and Pricing | Y | See Plans and Pricing | |||
Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-002 | Aug 3, 2017 | RX | Yes | No | 10,561,808 | See Plans and Pricing | Y | See Plans and Pricing | |||
Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-001 | Aug 3, 2017 | RX | Yes | No | 8,931,476 | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Norton Waterford
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-001 | Aug 3, 2017 | 6,446,627 | See Plans and Pricing |
Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-002 | Aug 3, 2017 | 6,446,627 | See Plans and Pricing |
Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-002 | Aug 3, 2017 | 7,637,260 | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Norton Waterford Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 2799102 | See Plans and Pricing |
China | 105903112 | See Plans and Pricing |
Japan | 2015231585 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.